JP2022553313A5 - - Google Patents
Info
- Publication number
- JP2022553313A5 JP2022553313A5 JP2022523448A JP2022523448A JP2022553313A5 JP 2022553313 A5 JP2022553313 A5 JP 2022553313A5 JP 2022523448 A JP2022523448 A JP 2022523448A JP 2022523448 A JP2022523448 A JP 2022523448A JP 2022553313 A5 JP2022553313 A5 JP 2022553313A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- amount
- contained
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025033867A JP2025074286A (ja) | 2019-10-23 | 2025-03-04 | セレキシパグを含む医薬組成物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP2019078905 | 2019-10-23 | ||
| EPPCT/EP2019/078905 | 2019-10-23 | ||
| PCT/EP2020/079698 WO2021078835A1 (en) | 2019-10-23 | 2020-10-22 | Pharmaceutical composition comprising selexipag |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025033867A Division JP2025074286A (ja) | 2019-10-23 | 2025-03-04 | セレキシパグを含む医薬組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022553313A JP2022553313A (ja) | 2022-12-22 |
| JP2022553313A5 true JP2022553313A5 (enExample) | 2023-10-30 |
| JP7646646B2 JP7646646B2 (ja) | 2025-03-17 |
Family
ID=75620412
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022523448A Active JP7646646B2 (ja) | 2019-10-23 | 2020-10-22 | セレキシパグを含む医薬組成物 |
| JP2025033867A Pending JP2025074286A (ja) | 2019-10-23 | 2025-03-04 | セレキシパグを含む医薬組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025033867A Pending JP2025074286A (ja) | 2019-10-23 | 2025-03-04 | セレキシパグを含む医薬組成物 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20220401441A1 (enExample) |
| EP (1) | EP4048235A1 (enExample) |
| JP (2) | JP7646646B2 (enExample) |
| KR (1) | KR20220087443A (enExample) |
| CN (1) | CN114555088A (enExample) |
| AU (1) | AU2020369912A1 (enExample) |
| BR (1) | BR112022007207A2 (enExample) |
| CA (1) | CA3154802A1 (enExample) |
| EC (1) | ECSP22040921A (enExample) |
| IL (1) | IL292354A (enExample) |
| JO (1) | JOP20220093A1 (enExample) |
| MX (1) | MX2022004882A (enExample) |
| PE (1) | PE20221455A1 (enExample) |
| PH (1) | PH12022550937A1 (enExample) |
| WO (1) | WO2021078835A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TR2022005274A1 (tr) * | 2022-04-05 | 2023-10-23 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Seleksi̇pag'in bi̇r kati di̇spersi̇yonunu i̇çeren bi̇r fi̇lm kapli tablet |
| TR2022005277A2 (tr) * | 2022-04-05 | 2023-10-23 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Yaş granülasyon i̇le i̇şlenmi̇ş seleksi̇pag i̇çeren bi̇r fi̇lm kapli tablet |
| TR2022005273A2 (tr) * | 2022-04-05 | 2023-10-23 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Seleksi̇pag i̇çeren bi̇r fi̇lm kapli tablet |
| TR2022020995A1 (tr) * | 2022-12-28 | 2024-07-22 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Seleksi̇pag i̇çeren bi̇r tablet formülasyonu |
| CN116392491A (zh) * | 2023-04-11 | 2023-07-07 | 广东省实验动物监测所 | 司来帕格的药物组合物及其制备方法 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI316055B (enExample) | 2001-04-26 | 2009-10-21 | Nippon Shinyaku Co Ltd | |
| EP2246336B1 (en) | 2008-02-28 | 2020-07-01 | Nippon Shinyaku Co., Ltd. | Fibrosis inhibitor |
| WO2009154246A1 (ja) | 2008-06-19 | 2009-12-23 | 日本新薬株式会社 | 勃起不全治療剤 |
| SI2289518T1 (sl) | 2008-06-23 | 2017-02-28 | Nippon Shinyaku Co., Ltd. | Terapevtsko sredstvo za vnetno črevesno bolezen |
| WO2009157397A1 (ja) | 2008-06-23 | 2009-12-30 | 日本新薬株式会社 | 非ステロイド性抗炎症剤投与に伴う腸管傷害治療剤 |
| HRP20151443T1 (hr) | 2008-06-23 | 2016-01-29 | Nippon Shinyaku Co., Ltd. | Terapijsko sredstvo protiv stenoze kralježniäśnog kanala |
| SG176915A1 (en) | 2009-06-26 | 2012-01-30 | Nippon Shinyaku Co Ltd | Crystals |
| WO2011024874A1 (ja) | 2009-08-26 | 2011-03-03 | 日本新薬株式会社 | 塩基付加塩 |
| AU2012296953B2 (en) | 2011-08-12 | 2016-10-20 | Ascendis Pharma A/S | Sustained release composition of prostacyclin |
| ES2733998T3 (es) | 2012-10-29 | 2019-12-03 | Cardio Incorporated | Agente terapéutico específico de enfermedad pulmonar |
| SG11201804320QA (en) * | 2015-12-02 | 2018-06-28 | Nippon Shinyaku Co Ltd | Pharmaceutical composition containing 2-{4-[n-(5,6- diphenylpyrazin-2-yl)-n-isopropylamino]butyloxy}-n- (methylsulfonyl)acetamide |
| JOP20190204A1 (ar) * | 2017-03-08 | 2019-09-05 | Actelion Pharmaceuticals Ltd | تركيبة صيدلانية تشتمل على سيليكسيباغ |
| AR114399A1 (es) * | 2018-02-21 | 2020-09-02 | Nippon Shinyaku Co Ltd | Composición granular, método de producción para composición granular y método de mejora de la propiedad de disolución para composición granular |
| EP3965767A1 (en) * | 2019-05-06 | 2022-03-16 | Actelion Pharmaceuticals Ltd | Methods for treating sarcoidosis-associated pulmonary hypertension |
-
2020
- 2020-10-22 JP JP2022523448A patent/JP7646646B2/ja active Active
- 2020-10-22 KR KR1020227012736A patent/KR20220087443A/ko not_active Withdrawn
- 2020-10-22 CN CN202080071283.2A patent/CN114555088A/zh active Pending
- 2020-10-22 PE PE2022000625A patent/PE20221455A1/es unknown
- 2020-10-22 EP EP20792448.1A patent/EP4048235A1/en active Pending
- 2020-10-22 JO JOP/2022/0093A patent/JOP20220093A1/ar unknown
- 2020-10-22 AU AU2020369912A patent/AU2020369912A1/en not_active Abandoned
- 2020-10-22 CA CA3154802A patent/CA3154802A1/en active Pending
- 2020-10-22 BR BR112022007207A patent/BR112022007207A2/pt not_active IP Right Cessation
- 2020-10-22 US US17/770,155 patent/US20220401441A1/en not_active Abandoned
- 2020-10-22 MX MX2022004882A patent/MX2022004882A/es unknown
- 2020-10-22 IL IL292354A patent/IL292354A/en unknown
- 2020-10-22 WO PCT/EP2020/079698 patent/WO2021078835A1/en not_active Ceased
- 2020-10-22 PH PH1/2022/550937A patent/PH12022550937A1/en unknown
-
2022
- 2022-05-20 EC ECSENADI202240921A patent/ECSP22040921A/es unknown
-
2025
- 2025-03-04 JP JP2025033867A patent/JP2025074286A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2935800T3 (es) | Forma de dosificación oral de ketamina | |
| JPWO2011111818A1 (ja) | モサプリドまたはその塩を含む徐放型医薬組成物 | |
| EP2205279B1 (en) | Pharmaceutical combination of aliskiren and valsartan | |
| CN1562024A (zh) | 一种治疗心血管疾病含盐酸雷诺嗪的口服制剂 | |
| CN101132777A (zh) | 用于睡眠障碍的药物组合物 | |
| JP2000511170A (ja) | 医薬組成物 | |
| JP2002097132A (ja) | シロスタゾール有核錠 | |
| AU2001272243A1 (en) | Rapid onset formulation | |
| JP2012516299A (ja) | 有機化合物のガレヌス製剤 | |
| WO2010082220A2 (en) | Sustained release pharmaceutical composition of quetiapine and process for preparation thereof | |
| US20200330433A1 (en) | Extended release pharmaceutical composition of apremilast | |
| MXPA06002023A (es) | Nueva formulacion de ropinirol. | |
| JP4970452B2 (ja) | メトホルミン徐放性錠剤およびその製造方法 | |
| WO2019098300A1 (ja) | 放出制御製剤 | |
| JP2022532766A5 (enExample) | ||
| CA3154802A1 (en) | Pharmaceutical composition comprising selexipag | |
| CN106794149A (zh) | 含ω‑3脂肪酸酯和他汀类的口服给药复合制剂 | |
| TW202139999A (zh) | 經修飾釋放之醫藥組合物、包含其之膠囊、錠劑和配方及其用途 | |
| JP2012515757A (ja) | トリメタジジンの放出調節固形薬剤組成物及びその製造方法 | |
| WO2014003371A1 (ko) | 아세브로필린을 포함하는 속효성과 지속성을 동시에 갖는 약제학적 조성물 | |
| JP2001522882A (ja) | ザファルカストを含有する医薬品組成物 | |
| TWI436760B (zh) | 阿利克侖之蓋崙（ｇａｌｅｎｉｃａｌ）調配物 | |
| JP2016113441A (ja) | プラミペキソール二塩酸塩一水和物を含む放出が延長された錠剤 | |
| JP2025535941A5 (enExample) | ||
| WO2018211336A2 (en) | Solid dosage form containing sorafenib tosylate |